Skip to main content
Year archive

Bliss GVS Pharma Limited — 2023 filings

All 129 regulatory filings released by Bliss GVS Pharma Limited (BLISSGVS) in 2023, sourced directly from the official regulator.

129 Filings
2023 Period
2023 filings (129)
Filing Released Lang
Trading Window
Regulatory Filings
2023-12-28 English
This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings
2023-12-28 English
Loss of Share Certificates
Regulatory Filings
2023-12-21 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Dislosure Requirements) Regulations, 2015, this is to inform you that our Registrar and Share ....
Regulatory Filings
2023-12-21 English
Loss of Share Certificates
Regulatory Filings
2023-12-21 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that our Registrar and Share ....
Regulatory Filings
2023-12-21 English
Copy of Newspaper Publication
Regulatory Filings
2023-11-03 English
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper advertisement ....
Regulatory Filings
2023-11-03 English
Outcome of Board Meeting
Regulatory Filings
2023-11-01 English
We would like to inform you that the Board Meeting of the Company was held today i.e. Wednesday, November 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 ....
Regulatory Filings
2023-11-01 English
Financial Result Updates
Regulatory Filings
2023-11-01 English
We would like to inform you that the Board Meeting of the Company was held today i.e. Wednesday, November 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 ....
Regulatory Filings
2023-11-01 English
Board Meeting — BLISS GVS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 01-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for…
Regulatory Filings
2023-10-25 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings
2023-10-25 English
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2023-10-25 English
Loss of Share Certificates
Regulatory Filings
2023-10-23 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share ....
Regulatory Filings
2023-10-23 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-10-10 English
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities ....
Regulatory Filings
2023-10-10 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-10-09 English
We would like to inform that, the ESOP Allotment Committee of the Company at its meeting held on October 09, 2023, has approved the allotment of 2,74,150 equity shares of face value of ....
Regulatory Filings
2023-10-09 English
Trading Window
Regulatory Filings
2023-09-29 English
This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings
2023-09-29 English
Updates
Regulatory Filings
2023-09-10 English
We refer to our submission of disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 dated September 07, 2023, this is to inform you ....
Regulatory Filings
2023-09-10 English
Updates
Regulatory Filings
2023-09-07 English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015 ("SEBI Listing Regulation") read with Clause 19 ....
Regulatory Filings
2023-09-07 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-08-29 English
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on August 29, 2023, has approved the allotment of 1,17,750 equity shares of face value ....
Regulatory Filings
2023-08-29 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings
2023-08-25 English
Please find enclosed herewith the reports related to the violation of the Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons ....
Regulatory Filings
2023-08-25 English
Copy of Newspaper Publication
Regulatory Filings
2023-08-03 English
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper advertisement ....
Regulatory Filings
2023-08-03 English
Outcome of Board Meeting
Regulatory Filings
2023-08-01 English
Financial Result Updates
Regulatory Filings
2023-08-01 English
We would like to inform you that the Board Meeting of the Company was held today i.e. Tuesday, August 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 and ....
Regulatory Filings
2023-08-01 English
Board Meeting — BLISS GVS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 01-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for t…
Regulatory Filings
2023-07-28 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-07-26 English
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on July 26, 2023, has approved the allotment of 57,750 equity shares of face value of Re. ....
Regulatory Filings
2023-07-26 English
Copy of Newspaper Publication
Regulatory Filings
2023-07-26 English
Updates
Regulatory Filings
2023-07-26 English
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of the newspaper advertisement of the notice published ....
Regulatory Filings
2023-07-26 English
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the communication sent to those concerned shareholders, ....
Regulatory Filings
2023-07-26 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings
2023-07-24 English
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2023 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2023-07-24 English
Price movement
Regulatory Filings
2023-07-20 English
Please find enclosed herewith Clarification Letter regarding Price movement sought by BSE Limited.
Regulatory Filings
2023-07-20 English
Shareholders meeting
Regulatory Filings
2023-07-20 English
In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 38th Annual General Meeting ....
Regulatory Filings
2023-07-20 English
Please find enclosed herewith proceedings of the 38th Annual General Meeting held on Wednesday, July 19, 2023 at 11:00 a.m. through Video Conferencing ("VC")/Other Audio-Visual Means ("OVAM").
Regulatory Filings
2023-07-19 English
Shareholders meeting
Regulatory Filings
2023-07-19 English
Updates
Regulatory Filings
2023-07-19 English
Please find enclosed herewith Outcome of 38th Annual General Meeting ("AGM") of the Company held today i.e. Wednesday, July 19, 2023.
Regulatory Filings
2023-07-19 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-07-13 English
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities ....
Regulatory Filings
2023-07-13 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-07-07 English
Loss of Share Certificates
Regulatory Filings
2023-07-01 English
Copy of Newspaper Publication
Regulatory Filings
2023-07-01 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share ....
Regulatory Filings
2023-07-01 English
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisement pertaining to the Notice ....
Regulatory Filings
2023-07-01 English
Trading Window
Regulatory Filings
2023-06-30 English
This is to inform you that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) ....
Regulatory Filings
2023-06-30 English
This is further to our letter dated May 11, 2023, wherein the Company had informed that the 38th Annual General Meeting (38th AGM) of the Company is scheduled to be held on Wednesday, July ....
Regulatory Filings
2023-06-27 English
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the Business ....
Regulatory Filings
2023-06-27 English
Updates
Regulatory Filings
2023-06-27 English
Pursuant to Regulation 30 read with Para A, Part A of Schedule III of the SEBI Listing Regulations, 2015, please find enclosed herewith the Notice of the 38th AGM of Bliss GVS Pharma Limited ....
Regulatory Filings
2023-06-27 English
Shareholders meeting
Regulatory Filings
2023-06-27 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-06-23 English
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 23, 2023, has approved the allotment of 26,000 equity shares of face value of Re. ....
Regulatory Filings
2023-06-23 English
Copy of Newspaper Publication
Regulatory Filings
2023-06-23 English
Pursuant to Regulation 30 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith ....
Regulatory Filings
2023-06-23 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share ....
Regulatory Filings
2023-06-19 English
Loss of Share Certificates
Regulatory Filings
2023-06-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs
Regulatory Filings
2023-06-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs
Regulatory Filings
2023-06-19 English
Updates
Regulatory Filings
2023-06-15 English
Further to the information dated March 18, 2023, we hereby notify that the United States Food and Drug Administration (US FDA) conducted a Pre-Approval Inspection (PAI) and Good Manufacturing ....
Regulatory Filings
2023-06-15 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-06-02 English
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 02, 2023, has approved the allotment of 44,500 equity shares of face value of Re. ....
Regulatory Filings
2023-06-02 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-30 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please ....
Regulatory Filings
2023-05-30 English
Updates
Regulatory Filings
2023-05-16 English
Copy of Newspaper Publication
Regulatory Filings
2023-05-15 English
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of the newspaper ....
Regulatory Filings
2023-05-15 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2023-05-15 English
ESOP/ESOS/ESPS
Regulatory Filings
2023-05-12 English
Pursuant to Regulation 30 of Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations'') read with Para B ....
Regulatory Filings
2023-05-12 English
Book Closure
Regulatory Filings
2023-05-12 English
Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") ....
Regulatory Filings
2023-05-12 English
Related Party Transactions
Regulatory Filings
2023-05-11 English
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith a disclosure ....
Regulatory Filings
2023-05-11 English
Recommended Final Dividend of 50% i.e. 0.50 paisa per equity share having face value of Rs.1/- each for the financial year ended March 31, 2023, subject to approval of the shareholders ....
Regulatory Filings
2023-05-11 English
Dividend Updates
Regulatory Filings
2023-05-11 English
We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 11, 2023 at the registered office of the Company. In pursuant to Regulation ....
Regulatory Filings
2023-05-11 English
Financial Result Updates
Regulatory Filings
2023-05-11 English
Board Meeting — BLISS GVS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 11-May-2023 to consider financial statements for the period ended March 2023, Financial results/Di…
Regulatory Filings
2023-05-05 English
Board Meeting Intimation
Regulatory Filings
2023-05-04 English
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2023 ,inter alia, to consider and approve a) To consider and approve ....
Regulatory Filings
2023-05-04 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-28 English
Please find enclosed herewith the yearly compliance certificate issued by the Company Secretary in Practice as per Regulation 40(9) of the Securities and Exchange Board of India (Listing ....
Regulatory Filings
2023-04-13 English
Please find enclosed herewith the compliance certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-04-11 English
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities ....
Regulatory Filings
2023-04-07 English
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, ....
Regulatory Filings
2023-04-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-04-07 English
Credit Rating
Regulatory Filings
2023-04-07 English
Trading Window
Regulatory Filings
2023-03-31 English
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading ....
Regulatory Filings
2023-03-31 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Registrar and Share ....
Regulatory Filings
2023-03-23 English
Loss of Share Certificates
Regulatory Filings
2023-03-23 English
Updates
Regulatory Filings
2023-03-18 English
This is to inform you that the United States Food and Drug Administration (US FDA) conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practice (GMP) inspection at the Company''s ....
Regulatory Filings
2023-03-18 English
Loss of Share Certificates
Regulatory Filings
2023-03-17 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings
2023-03-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath & PACs
Regulatory Filings
2023-03-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath & PACs
Regulatory Filings
2023-03-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath & PACs
Regulatory Filings
2023-02-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath & PACs
Regulatory Filings
2023-02-20 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings
2023-02-14 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings
2023-02-02 English
Loss of Share Certificates
Regulatory Filings
2023-01-31 English
Copy of Newspaper Publication
Regulatory Filings
2023-01-30 English
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper ....
Regulatory Filings
2023-01-30 English
We would like to inform you that, Board Meeting of the Company was held today i.e. Tuesday, January 24, 2023 at the registered office of the Company. In pursuant to Regulation 30 and 33 ....
Regulatory Filings
2023-01-24 English
Financial Result Updates
Regulatory Filings
2023-01-24 English
Board Meeting — Financial Results
Regulatory Filings
2023-01-18 English
Updates
Regulatory Filings
2023-01-17 English
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2023 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2023-01-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-01-12 English
Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities ....
Regulatory Filings
2023-01-12 English